Search results
Pfizer (NYSE:PFE) Stock Price Down 0.9%
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) was down 0.9% during trading on Thursday . The company traded as low as $27.20 and last traded at $27.41. Approximately 11,513,196 ...
Raleigh Capital Management Inc. Sells 2,270 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 13 hours agoThe firm owned 64,481 shares of the biopharmaceutical company’s stock after selling 2,270 shares during the quarter. Raleigh Capital Management Inc.’s holdings in
Pfizer Inc. (NYSE:PFE) Position Increased by V Square Quantitative Management LLC
ETF DAILY NEWS· 14 hours agoThe institutional investor owned 20,985 shares of the biopharmaceutical company’s stock after acquiring an additional 15,158 shares during the period. V Square Quantitative ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 7 days agoDuring this period, the Zacks Large Cap Pharmaceuticals industry, which Pfizer falls in, has gained 5.8%. The key question now is: What could be the stock
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 22 hours agoPfizer reported first-quarter sales that rose 11% year over year if we exclude Comirnaty and...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 3 days agoBenefits For Regenxbio, Solid But most analysts didn't consider Pfizer a serious competitor. "The...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoThe fund bought 2,998 shares of the biopharmaceutical company’s stock, valued at approximately $86,000. Taylor Financial Group Inc. bought a new stake in Pfizer< ...
Billionaires Are Buying These 2 Ultra-High-Yield Dividend Stocks Hand Over Fist. Are They Smart Buys...
Motley Fool via Yahoo Finance· 5 days agoAt recent prices, Pfizer shares offer a 5.9% yield and the confidence that comes with 15 consecutive...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 3 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...